These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 34865617)

  • 1. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
    Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA
    Front Public Health; 2021; 9():709369. PubMed ID: 34368071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age structure and vaccine prioritization on COVID-19 in West Africa.
    Taboe HB; Asare-Baah M; Yesmin A; Ngonghala CN
    Infect Dis Model; 2022 Dec; 7(4):709-727. PubMed ID: 36097593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study.
    Li J; Giabbanelli P
    JMIR Med Inform; 2021 Apr; 9(4):e27419. PubMed ID: 33872188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage.
    Christie A; Brooks JT; Hicks LA; Sauber-Schatz EK; Yoder JS; Honein MA;
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(30):1044-1047. PubMed ID: 34324480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?
    Kim HY; Bershteyn A; McGillen JB; Braithwaite RS
    BMC Public Health; 2023 Jan; 23(1):174. PubMed ID: 36698103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies.
    Shaker M; Abrams EM; Greenhawt M
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2658-2668.e3. PubMed ID: 33711496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar.
    Rasambainarivo F; Ramiadantsoa T; Raherinandrasana A; Randrianarisoa S; Rice BL; Evans MV; Roche B; Randriatsarafara FM; Wesolowski A; Metcalf JC
    BMC Public Health; 2022 Apr; 22(1):724. PubMed ID: 35413894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study.
    Li R; Li Y; Zou Z; Liu Y; Li X; Zhuang G; Shen M; Zhang L
    Front Public Health; 2021; 9():801763. PubMed ID: 35083192
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.
    Moghadas SM; Vilches TN; Zhang K; Wells CR; Shoukat A; Singer BH; Meyers LA; Neuzil KM; Langley JM; Fitzpatrick MC; Galvani AP
    Clin Infect Dis; 2021 Dec; 73(12):2257-2264. PubMed ID: 33515252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A flexible age-dependent, spatially-stratified predictive model for the spread of COVID-19, accounting for multiple viral variants and vaccines.
    Schneider KA; Tsoungui Obama HCJ; Adil Mahmoud Yousif N
    PLoS One; 2023; 18(1):e0277505. PubMed ID: 36662784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
    Vilches TN; Zhang K; Van Exan R; Langley JM; Moghadas SM
    Vaccine; 2021 Apr; 39(17):2360-2365. PubMed ID: 33812742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
    Dabanch J; Bastías M; Endeiza ML; Díaz E; Inostroza J; Cerda J; Santillana S; Rodríguez J; González C; Rodríguez M; Pizarro A
    Rev Chilena Infectol; 2021 Apr; 38(2):185-188. PubMed ID: 34184708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA fall 2023 vaccines in the United States.
    Kohli MA; Maschio M; Joshi K; Lee A; Fust K; Beck E; Van de Velde N; Weinstein MC
    J Med Econ; 2023; 26(1):1532-1545. PubMed ID: 37961887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.